Pre-clinical pharmacokinetic and metabolomic analyses of isorhapontigenin, a dietary resveratrol derivative

10.3389/fphar.2018.00753

Saved in:
Bibliographic Details
Main Authors: Dai, Y, Yeo, S.C.M, Barnes, P.J, Donnelly, L.E, Loo, L.C, Lin, H.-S
Other Authors: PHARMACY
Format: Article
Published: 2020
Subjects:
rat
Online Access:https://scholarbank.nus.edu.sg/handle/10635/175376
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-175376
record_format dspace
spelling sg-nus-scholar.10635-1753762024-04-05T09:03:17Z Pre-clinical pharmacokinetic and metabolomic analyses of isorhapontigenin, a dietary resveratrol derivative Dai, Y Yeo, S.C.M Barnes, P.J Donnelly, L.E Loo, L.C Lin, H.-S PHARMACY allantoin arachidonic acid cadaverine cholesterol fructose isorhapontigenin resveratrol tryptamine unclassified drug animal experiment area under the curve Article controlled study drug absorption drug bioavailability drug blood level drug clearance drug dose escalation limit of quantitation liquid chromatography-mass spectrometry male mass fragmentography mean residence time metabolomics nonhuman rat single drug dose 10.3389/fphar.2018.00753 Frontiers in Pharmacology 9 JUN 753 2020-09-09T10:05:18Z 2020-09-09T10:05:18Z 2018 Article Dai, Y, Yeo, S.C.M, Barnes, P.J, Donnelly, L.E, Loo, L.C, Lin, H.-S (2018). Pre-clinical pharmacokinetic and metabolomic analyses of isorhapontigenin, a dietary resveratrol derivative. Frontiers in Pharmacology 9 (JUN) : 753. ScholarBank@NUS Repository. https://doi.org/10.3389/fphar.2018.00753 1663-9812 https://scholarbank.nus.edu.sg/handle/10635/175376 Unpaywall 20200831
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic allantoin
arachidonic acid
cadaverine
cholesterol
fructose
isorhapontigenin
resveratrol
tryptamine
unclassified drug
animal experiment
area under the curve
Article
controlled study
drug absorption
drug bioavailability
drug blood level
drug clearance
drug dose escalation
limit of quantitation
liquid chromatography-mass spectrometry
male
mass fragmentography
mean residence time
metabolomics
nonhuman
rat
single drug dose
spellingShingle allantoin
arachidonic acid
cadaverine
cholesterol
fructose
isorhapontigenin
resveratrol
tryptamine
unclassified drug
animal experiment
area under the curve
Article
controlled study
drug absorption
drug bioavailability
drug blood level
drug clearance
drug dose escalation
limit of quantitation
liquid chromatography-mass spectrometry
male
mass fragmentography
mean residence time
metabolomics
nonhuman
rat
single drug dose
Dai, Y
Yeo, S.C.M
Barnes, P.J
Donnelly, L.E
Loo, L.C
Lin, H.-S
Pre-clinical pharmacokinetic and metabolomic analyses of isorhapontigenin, a dietary resveratrol derivative
description 10.3389/fphar.2018.00753
author2 PHARMACY
author_facet PHARMACY
Dai, Y
Yeo, S.C.M
Barnes, P.J
Donnelly, L.E
Loo, L.C
Lin, H.-S
format Article
author Dai, Y
Yeo, S.C.M
Barnes, P.J
Donnelly, L.E
Loo, L.C
Lin, H.-S
author_sort Dai, Y
title Pre-clinical pharmacokinetic and metabolomic analyses of isorhapontigenin, a dietary resveratrol derivative
title_short Pre-clinical pharmacokinetic and metabolomic analyses of isorhapontigenin, a dietary resveratrol derivative
title_full Pre-clinical pharmacokinetic and metabolomic analyses of isorhapontigenin, a dietary resveratrol derivative
title_fullStr Pre-clinical pharmacokinetic and metabolomic analyses of isorhapontigenin, a dietary resveratrol derivative
title_full_unstemmed Pre-clinical pharmacokinetic and metabolomic analyses of isorhapontigenin, a dietary resveratrol derivative
title_sort pre-clinical pharmacokinetic and metabolomic analyses of isorhapontigenin, a dietary resveratrol derivative
publishDate 2020
url https://scholarbank.nus.edu.sg/handle/10635/175376
_version_ 1800914360893177856